Acurx Pharmaceuticals Inc. – Filings and Transcripts

NASDAQ: ACXP
Share price (5/28/26): $1.99
Market cap (5/28/26): $8.552 million

Warning: Large portions of this site require JavaScript enabled in order to function properly. Please make sure JavaScript is enabled in your browser.

Please let us know at support@bamsec.com if you have any questions or concerns.

Search in Documents

Key Exhibits

External Links

Financials Filter

ended 03/31/26 Q1

ended 12/31/25 FY 2025

ended 09/30/25 Q3

ended 06/30/25 Q2

ended 03/31/25 Q1

Prospectuses and Registrations Filter

Prospectus supplement

Prospectus supplement

Initial registration of new securities

Initial registration of new securities

Exempt offering of securities

Ownership Filter

Donohue James J.

Harrison Thomas L

Scodari Joseph C

News Filter

Announces Up to $7.1 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules

Announces New Ibezapolstat Clinical Trial Program in Patients With Recurrent CDI That Has the Potential to Shift the Paradigm of Treatment and Prevention of C. Difficile Infection

Amendment to Articles of Incorporation or Bylaws, or Change in Fiscal Year, Financial Statements or Exhibits

Shareholder Vote Results

Announces Reverse Stock Split

Proxies Filter

Additional info about upcoming vote

Definitive proxy

Preliminary proxy

Additional info about upcoming vote

Definitive proxy

Other Filter

Notice of effectiveness

Notice of effectiveness

Notice of effectiveness

Correspondence with the SEC

Letter from the SEC